Summary & Overview
CPT 38207: Management of Hematopoietic Progenitor Cell Preservation
CPT code 38207 covers the physician or provider service managing preservation and storage of harvested hematopoietic progenitor cells (HPCs) to ensure viability for future transplantation. This code captures the clinical oversight role distinct from the physical collection, processing, or infusion of cells and is increasingly relevant as cellular therapies and stem cell transplants expand nationally. Payers commonly involved in coverage decisions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what CPT code 38207 represents, the clinical context for use, and the primary issues that affect billing and coverage such as site of service distinctions, documentation expectations, and how this oversight service is categorized relative to collection and storage procedures. The publication summarizes national benchmarking considerations, payer policy patterns where available, and recent policy trends affecting transplantation support services. Data not available in the input is noted where applicable, including detailed payer-specific coverage rules, utilization metrics, and associated ICD-10 diagnoses.
Billing Code Overview
CPT code 38207 describes the provider's management of preservation and storage of harvested hematopoietic progenitor cells (HPCs). The service involves assuring that collected HPCs are preserved according to current protocols for future autologous or allogeneic transplantation.
-
Service type: Cell preservation and storage management
-
Typical site of service: Hospital-based apheresis or cellular therapy laboratory and associated transplant center facilities
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric candidate for autologous or allogeneic hematopoietic progenitor cell (HPC) transplantation, such as a patient with hematologic malignancy (e.g., acute leukemia, lymphoma, or multiple myeloma) who has undergone mobilization and apheresis to collect peripheral blood stem cells or a patient who had bone marrow harvest. After collection, a transplantation physician, affiliated transplant coordinator, or cellular therapy specialist manages processing, cryopreservation, storage, and documentation of the harvested HPC product. The clinical workflow includes receipt of the collected product from the apheresis or operating room team, verification of donor/patient identifiers, assessment of product volume and cell counts, addition of cryoprotectant (commonly dimethyl sulfoxide), controlled-rate freezing per institutional protocol, labeling and chain-of-custody documentation, placement into long-term cryogenic storage, and ongoing inventory and release management for future infusion. The service is typically performed in an inpatient or outpatient hospital-based transfusion/cell-processing laboratory, a dedicated cellular therapy processing facility, or a hospital blood bank with cryopreservation capabilities. Billing occurs when the provider assumes responsibility for preservation and storage oversight according to protocols in anticipation of future transplantation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Standard/Default Professional Component |